Information Provided By: 
Fly News Breaks for April 7, 2015
CLVS, TSRO
Apr 7, 2015 | 08:45 EDT
Leerink believes TESARO (TSRO) could potentially be in a similar position to Clovis (CLVS) and seek Breakthrough Therapy designation for niraparib in the coming months, although it points out its unclear whether TESARO will pursue this. The firm thinks the BTD for Clovis represents a "significant" milestone for the company.
News For TSRO;CLVS From the Last 2 Days
There are no results for your query TSRO;CLVS
